We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+7.85%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.76B
AUM Growth
+$1.71M
Cap. Flow
-$65.7M
Cap. Flow %
-3.73%
Top 10 Hldgs %
24.81%
Holding
276
New
14
Increased
59
Reduced
180
Closed
14

Top Buys

Rank Stock Value
1
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$15M
2
EB
Eventbrite
EB
+$9.72M
3
ESTA icon
Establishment Labs
ESTA
+$9.35M
4
PRO
PROS Holdings
PRO
+$7.11M
5
PCRX icon
Pacira BioSciences
PCRX
+$6.75M

Top Sells

Rank Stock Value
1
SMTC icon
Semtech
SMTC
+$13.7M
2
MED icon
Medifast
MED
+$11.8M
3
PINC
Premier
PINC
+$11M
4
RVNC
Revance Therapeutics, Inc.
RVNC
+$8M
5
MEDP icon
Medpace
MEDP
+$7.15M

Sector Composition

Rank Sector Weight
1 Healthcare 28.23%
2 Technology 24.76%
3 Industrials 19.11%
4 Consumer Discretionary 9.18%
5 Communication Services 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WWE
1
DELISTED
World Wrestling Entertainment
WWE
$51.6M 2.93%
475,452
-40,121
-8% -$4.15M
DOOR
2
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$50.8M 2.88%
495,614
-2,327
-0.5% -$218K
WNS
3
DELISTED
WNS Holdings
WNS
$49.9M 2.83%
677,225
+68,127
+11% +$5.45M
DFIN icon
4
Donnelley Financial Solutions
DFIN
$1.21B
$48.7M 2.76%
1,069,556
-1,740
-0.2% -$76.8K
EEFT icon
5
Euronet Worldwide
EEFT
$2.77B
$48.1M 2.73%
409,665
-6,667
-2% -$745K
LRN icon
6
Stride
LRN
$3.48B
$42.7M 2.42%
1,146,581
-3,244
-0.3% -$130K
ARLO icon
7
Arlo Technologies
ARLO
$1.59B
$40.3M 2.29%
3,697,504
-3,472
-0.1% -$28.2K
PCRX icon
8
Pacira BioSciences
PCRX
$1.04B
$36.3M 2.06%
906,805
+163,209
+22% +$6.75M
ACIW icon
9
ACI Worldwide
ACIW
$5.81B
$34.8M 1.98%
1,502,659
-23,422
-2% -$566K
MEDP icon
10
Medpace
MEDP
$16B
$34M 1.93%
141,415
-34,437
-20% -$7.15M
PBH icon
11
Prestige Consumer Healthcare
PBH
$2.35B
$33.5M 1.9%
563,670
-7,593
-1% -$454K
ZD icon
12
Ziff Davis
ZD
$1.92B
$31M 1.76%
442,317
-55
-0% -$3.77K
AGM icon
13
Federal Agricultural Mortgage
AGM
$2.38B
$26.7M 1.52%
185,824
-1,862
-1% -$255K
BBBY
14
Bed Bath & Beyond
BBBY
$470M
$26.5M 1.5%
893,660
-1,319
-0.1% -$24.4K
LCII icon
15
LCI Industries
LCII
$2.46B
$26.4M 1.5%
208,778
-2,957
-1% -$339K
DOCS icon
16
Doximity
DOCS
$3.74B
$26.3M 1.49%
773,777
-12,255
-2% -$408K
AX icon
17
Axos Financial
AX
$5.69B
$24.1M 1.37%
611,164
-6,657
-1% -$258K
NGVT icon
18
Ingevity
NGVT
$2.48B
$21.4M 1.21%
367,625
+35,896
+11% +$2.15M
ACAD icon
19
Acadia Pharmaceuticals
ACAD
$4.35B
$21.2M 1.2%
886,453
-673
-0.1% -$15K
FC icon
20
Franklin Covey
FC
$236M
$21M 1.19%
481,264
+41,266
+9% +$1.53M
LGND icon
21
Ligand Pharmaceuticals
LGND
$5.82B
$20.8M 1.18%
288,159
-186
-0.1% -$14K
RDWR icon
22
Radware
RDWR
$1.07B
$18.8M 1.07%
968,636
+3,110
+0.3% +$62.2K
PGTI
23
DELISTED
PGT, Inc.
PGTI
$18.7M 1.06%
641,920
-649
-0.1% -$17.1K
XPO icon
24
XPO
XPO
$23.6B
$18.3M 1.04%
310,208
-5,063
-2% -$229K
AWI icon
25
Armstrong World Industries
AWI
$7.31B
$18.1M 1.02%
245,800
-3,991
-2% -$272K
1
2 3 4 5

Similar funds

GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
JCM
Jacobi Capital Management Pittston, Pennsylvania $1.79B AUM 17.94% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return

Rice Hall James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Rice Hall James & Associates held 276 positions worth $1.76B, up 0.1% from $1.76B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $65.7M in Q2 2023, closing 14 positions and reducing 180 holdings. Its most notable exit was Semtech, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in BioCryst Pharmaceuticals worth $13.2M.

  • Rice Hall James & Associates's largest Q2 2023 buy was BioCryst Pharmaceuticals: 1,872,964 shares worth $13.2M.
  • Rice Hall James & Associates added most to Eventbrite in Q2 2023, an estimated $9.72M increase.
  • Rice Hall James & Associates's biggest Q2 2023 reduction was Premier, cutting an estimated $11M.
  • Rice Hall James & Associates fully exited Semtech in Q2 2023, selling an estimated $13.7M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.76B portfolio in Q2 2023.
  • Rice Hall James & Associates opened 14 new positions and closed 14 in Q2 2023.
  • Rice Hall James & Associates's portfolio value rose 0.1% quarter-over-quarter to $1.76B.

Based on Rice Hall James & Associates's 13F filing for Q2 2023, filed 24 Jul 2023.